JP2022507269A5 - - Google Patents
Info
- Publication number
- JP2022507269A5 JP2022507269A5 JP2021525757A JP2021525757A JP2022507269A5 JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5 JP 2021525757 A JP2021525757 A JP 2021525757A JP 2021525757 A JP2021525757 A JP 2021525757A JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862760422P | 2018-11-13 | 2018-11-13 | |
| US62/760,422 | 2018-11-13 | ||
| PCT/US2019/061093 WO2020102285A1 (en) | 2018-11-13 | 2019-11-13 | Encapsulated polynucleotides and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507269A JP2022507269A (ja) | 2022-01-18 |
| JPWO2020102285A5 JPWO2020102285A5 (https=) | 2022-11-07 |
| JP2022507269A5 true JP2022507269A5 (https=) | 2022-11-07 |
Family
ID=70731661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525757A Pending JP2022507269A (ja) | 2018-11-13 | 2019-11-13 | カプセル化ポリヌクレオチド及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210403950A1 (https=) |
| EP (1) | EP3880812A4 (https=) |
| JP (1) | JP2022507269A (https=) |
| KR (1) | KR20210093285A (https=) |
| CN (1) | CN113348246A (https=) |
| AU (1) | AU2019381698A1 (https=) |
| BR (1) | BR112021009226A2 (https=) |
| CA (1) | CA3117924A1 (https=) |
| IL (1) | IL282992A (https=) |
| MX (1) | MX2021005448A (https=) |
| SG (1) | SG11202104887UA (https=) |
| WO (1) | WO2020102285A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11130787B2 (en) * | 2020-06-11 | 2021-09-28 | MBF Therapeutics, Inc. | Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods |
| MX2023009345A (es) * | 2021-02-10 | 2023-10-24 | Oncorus Inc | Compuestos, composiciones y metodos de uso de estos. |
| IT202200016386A1 (it) * | 2022-08-02 | 2024-02-02 | Univ Degli Studi Roma La Sapienza | Nanoparticelle lipidiche multicomponenti ad elevata fusogenicità cellulare per la veicolazione di acidi nucleici e relativo processo di preparazione |
| EP4658782A2 (en) * | 2023-02-02 | 2025-12-10 | The Regents of the University of California | Self-amplifying non-coding rna for targeted gene knockdown |
| EP4683655A1 (en) * | 2023-03-20 | 2026-01-28 | Dimberg, Anna | Tumor blood vessel-targeted aav therapy for cancer treatment |
| CN117487762A (zh) * | 2023-11-06 | 2024-02-02 | 中科佰乘(深圳)生物科技有限公司 | 一种细胞外囊泡、制备方法、药物组合物及应用 |
| CN119242712A (zh) * | 2024-09-27 | 2025-01-03 | 南京师范大学 | 特异性靶向骨骼肌细胞的携带miRNA-486基因的腺相关病毒载体、药物组合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1092777A1 (en) * | 1999-10-15 | 2001-04-18 | Aventis Pharma S.A. | Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| AU2002953436A0 (en) * | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| KR20060026854A (ko) * | 2003-05-28 | 2006-03-24 | 위스콘신 얼럼나이 리서어치 화운데이션 | ＰｏｌⅡ 프로모터 및 리보자임을 갖는 재조합 인플루엔자벡터 |
| WO2005030139A2 (en) * | 2003-09-26 | 2005-04-07 | Novartis Ag | Seneca valley virus based compositions and methods for treating disease |
| WO2006074526A1 (en) * | 2005-01-17 | 2006-07-20 | Viralytics Limited | Method and composition for treatment of neoplasms |
| US9006487B2 (en) * | 2005-06-15 | 2015-04-14 | Massachusetts Institute Of Technology | Amine-containing lipids and uses thereof |
| WO2016191684A1 (en) * | 2015-05-28 | 2016-12-01 | Finer Mitchell H | Genome editing vectors |
| EP3307308A2 (en) * | 2015-06-10 | 2018-04-18 | Hookipa Biotech AG | Hpv vaccines |
| RU2749050C2 (ru) * | 2016-01-27 | 2021-06-03 | Онкорус, Инк. | Онколитические вирусные векторы и их применение |
| RU2021127872A (ru) * | 2016-06-30 | 2021-11-09 | Онкорус, Инк. | Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов |
| EP3472318B1 (en) * | 2016-07-08 | 2023-09-06 | Exuma Biotech Corp. | Methods and compositions for transducing lymphocytes and regulating the activity thereof |
| EP3538515B1 (en) * | 2016-11-08 | 2022-07-20 | Ramot at Tel-Aviv University Ltd. | Cationic lipids for nucleic acid delivery and preparation thereof |
| AU2018301701A1 (en) * | 2017-07-14 | 2020-02-27 | Elevatebio Technologies, Inc. | Encapsulated polynucleotides and methods of use |
| CA3157063A1 (en) * | 2019-10-10 | 2021-04-15 | Oncorus, Inc. | Dual viruses and dual oncolytic viruses and methods of treatment |
-
2019
- 2019-11-13 EP EP19884039.9A patent/EP3880812A4/en not_active Withdrawn
- 2019-11-13 CN CN201980085641.2A patent/CN113348246A/zh active Pending
- 2019-11-13 WO PCT/US2019/061093 patent/WO2020102285A1/en not_active Ceased
- 2019-11-13 JP JP2021525757A patent/JP2022507269A/ja active Pending
- 2019-11-13 US US17/293,153 patent/US20210403950A1/en not_active Abandoned
- 2019-11-13 AU AU2019381698A patent/AU2019381698A1/en not_active Abandoned
- 2019-11-13 MX MX2021005448A patent/MX2021005448A/es unknown
- 2019-11-13 SG SG11202104887UA patent/SG11202104887UA/en unknown
- 2019-11-13 CA CA3117924A patent/CA3117924A1/en active Pending
- 2019-11-13 BR BR112021009226-9A patent/BR112021009226A2/pt not_active IP Right Cessation
- 2019-11-13 KR KR1020217017630A patent/KR20210093285A/ko not_active Ceased
-
2021
- 2021-05-06 IL IL282992A patent/IL282992A/en unknown